Lupin trades higher on the bourses

21 Sep 2017 Evaluate

Lupin is currently trading at Rs. 1035.10, up by 32.90 points or 3.28% from its previous closing of Rs. 1002.20 on the BSE.

The scrip opened at Rs. 1009.00 and has touched a high and low of Rs. 1038.90 and Rs. 1005.65 respectively. So far 1,82,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1572.25 on 06-Feb-2017 and a 52 week low of Rs. 920.00 on 21-Aug-2017.

Last one week high and low of the scrip stood at Rs. 1038.90 and Rs. 990.00 respectively. The current market cap of the company is Rs. 46,765.00 crore.

The promoters holding in the company stood at 46.70%, while Institutions and Non-Institutions held 40.66% and 12.63% respectively.

Lupin has received final approval for its Metronidazole Tablets USP, 250 mg and 500 mg from the United States Food and Drug Administration (USFDA) to market a generic version of G.D. Searle LLC’s Flagyl Tablets, 250 mg and 500 mg. Flagyl Tablets had US sales of $44.1 million as per IMS MAT June 2017.

The company’s Metronidazole Tablets USP, 250 mg and 500 mg are the AB rated generic equivalent of G.D. Searle LLC’s Flagyl Tablets, 250 mg and 500 mg. It is indicated in the treatment of wide variety of infections which are caused by particular types of bacteria and other infectious organisms.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.


Lupin Share Price

2072.70 17.65 (0.86%)
11-Dec-2025 11:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.95
Dr. Reddys Lab 1270.50
Cipla 1501.55
Zydus Lifesciences 921.10
Lupin 2072.70
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×